Adamas Pharmaceuticals, Inc. – NASDAQ:ADMS
Adamas Pharmaceuticals stock price today
$8.22
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
Adamas Pharmaceuticals stock price quarterly change
+0.86%
quarter
Adamas Pharmaceuticals stock price yearly change
+29.45%
year
Adamas Pharmaceuticals key metrics
Market Cap | N/A |
Enterprise value | 430.49M |
P/E | -5.97 |
EV/Sales | 4.88 |
EV/EBITDA | -11.32 |
Price/Sales | 4.25 |
Price/Book | -17.35 |
PEG ratio | -0.10 |
EPS | -1.70 |
Revenue | 88.18M |
EBITDA | -38.02M |
Income | -62.70M |
Revenue Q/Q | 28.35% |
Revenue Y/Y | 26.34% |
Profit margin | -71.11% |
Oper. margin | -44.56% |
Gross margin | 97.64% |
EBIT margin | -44.56% |
EBITDA margin | -43.12% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAdamas Pharmaceuticals stock price history
Adamas Pharmaceuticals stock forecast
Adamas Pharmaceuticals financial statements
| Dec 2020 | 21.01M | -18.27M | -86.97% |
|---|---|---|---|
| Mar 2021 | 19.31M | -12.57M | -65.11% |
| Jun 2021 | 21.97M | -12.34M | -56.18% |
| Sep 2021 | 25.89M | -19.51M | -75.37% |
| 2021-02-23 | -0.51 | -0.64 |
|---|---|---|
| 2021-05-10 | -0.51 | -0.36 |
| 2021-08-09 | -0.27 | -0.27 |
| 2021-11-10 | -0.22 | -0.43 |
| Dec 2020 | 120029000 | 170.00M | 141.64% |
|---|---|---|---|
| Mar 2021 | 169247000 | 163.31M | 96.49% |
| Jun 2021 | 150644000 | 154.67M | 102.68% |
| Sep 2021 | 143977000 | 165.58M | 115.01% |
| Dec 2020 | -10.32M | 29.91M | 1.27M |
|---|---|---|---|
| Mar 2021 | -21.06M | 7.79M | 66.44M |
| Jun 2021 | -9.17M | -26.84M | -8K |
| Sep 2021 | -6.24M | -3.00M | -921K |
Adamas Pharmaceuticals alternative data
| Aug 2023 | 138 |
|---|---|
| Sep 2023 | 138 |
| Oct 2023 | 138 |
| Nov 2023 | 138 |
| Dec 2023 | 138 |
| Jan 2024 | 138 |
| Feb 2024 | 138 |
| Mar 2024 | 138 |
| Apr 2024 | 138 |
| May 2024 | 138 |
| Jun 2024 | 138 |
| Jul 2024 | 138 |
Adamas Pharmaceuticals other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2020 | 0 | 2050 |
| Jan 2021 | 0 | 2630 |
| Feb 2021 | 0 | 8335 |
| Mar 2021 | 5975 | 3473 |
| Jun 2021 | 0 | 8200 |
| Patent |
|---|
Application Filling date: 11 Mar 2021 Issue date: 3 Mar 2022 |
Grant Filling date: 5 Jan 2018 Issue date: 27 Apr 2021 |
Grant Filling date: 30 Dec 2016 Issue date: 13 Apr 2021 |
| Quarter | Transcript |
|---|---|
| Q2 2021 9 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q1 2021 10 May 2021 | Q1 2021 Earnings Call Transcript |
| Q4 2020 23 Feb 2021 | Q4 2020 Earnings Call Transcript |
| Q2 2020 7 Aug 2020 | Q2 2020 Earnings Call Transcript |
-
What's the price of Adamas Pharmaceuticals stock today?
One share of Adamas Pharmaceuticals stock can currently be purchased for approximately $8.22.
-
When is Adamas Pharmaceuticals's next earnings date?
Unfortunately, Adamas Pharmaceuticals's (ADMS) next earnings date is currently unknown.
-
Does Adamas Pharmaceuticals pay dividends?
No, Adamas Pharmaceuticals does not pay dividends.
-
What is Adamas Pharmaceuticals's stock symbol?
Adamas Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "ADMS".
-
What is Adamas Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Adamas Pharmaceuticals?
Shares of Adamas Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Adamas Pharmaceuticals have?
As Jul 2024, Adamas Pharmaceuticals employs 138 workers.
-
When Adamas Pharmaceuticals went public?
Adamas Pharmaceuticals, Inc. is publicly traded company for more then 11 years since IPO on 10 Apr 2014.
-
What is Adamas Pharmaceuticals's official website?
The official website for Adamas Pharmaceuticals is adamaspharma.com.
-
Where are Adamas Pharmaceuticals's headquarters?
Adamas Pharmaceuticals is headquartered at 1900 Powell St Ste 1000, Emeryville, CALIFORNIA.
-
How can i contact Adamas Pharmaceuticals?
Adamas Pharmaceuticals's mailing address is 1900 Powell St Ste 1000, Emeryville, CALIFORNIA and company can be reached via phone at +1 510 450 3554.
Adamas Pharmaceuticals company profile:
Adamas Pharmaceuticals, Inc.
adamaspharma.comExchange:
NASDAQ
Full time employees:
138
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. The company offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. It is also developing ADS-5102 that is in Phase III clinical study to treat walking impairment in patients with multiple sclerosis and other indications; and ADS-4101, which has completed two Phase I studies for treating partial onset seizures in patients with epilepsy. In addition, the company offers Namzaric (memantine hydrochloride extended release and donepezil hydrochloride) capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Emeryville, California.
1900 Powell St Ste 1000
Emeryville, CALIFORNIA 94608
Emeryville, CALIFORNIA 94608
CIK: 0001328143
ISIN: US00548A1060
CUSIP: 00548A106
